Older adults may be more sensitive to the effects of fluoxetine. Ask your doctor about taking fluoxetine if you are pregnant.Taking an SSRI antidepressant during late pregnancy may cause serious medical complications in the baby. However, you may have a relapse of depression if you stop taking ...
General **BEERS Drug** Genetic Implications: Pronunciation: brex-pip-ra-zole Trade Name(s) Rexulti Ther. Class. antipsychotics antidepressants Pharm. Class. serotonin-dopamine activity modulators (SDAM) Indications Indications Indications Schizophrenia. Adjunctive treatment of major depressive disorder. Ag...
Otsuka and Lundbeck announce the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of REXULTI® (brexpiprazole) for the treatment of schizophrenia in pediatric patients 13 to 17 years of age. The FDA prev
Olanzapine belongs to a drug class known as atypical antipsychotics. Other members of this class includeclozapine(Clozaril),risperidone(Risperdal),aripiprazole(Abilify) andziprasidone(Geodon). The exact mechanism of action of olanzapine is not known. It may work by blocking receptors for several neuro...
Rexulti®brexpiprazole 2 mg tablets [product information].https://www.rexulti.com/us/mdd. Accessed 18 Nov 2016. Spritam®(levetiracetam) tablets for oral suspension [product information].https://www.spritam.com/. Accessed 18 Nov 2016. ...
headache, dizziness, urinary tract infection, nasopharyngitis, and sleep disturbances (both somnolence and insomnia). Rexulti will retain the Boxed Warning for medications in this class that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an...
(including fatal cases) has been reported with other agents in this class. Monitor complete blood count in patients with pre-existing low white blood cell count (WBC)/absolute neutrophil count or history of drug-induced leukopenia/neutropenia. Discontinue REXULTI at the first sign of a clinically...
(including fatal cases) has been reported with other agents in this class. Monitor complete blood count in patients with pre-existing low white blood cell count (WBC)/absolute neutrophil count or history of drug-induced leukopenia/neutropenia. Discontinue REXULTI at the first sign ...
(including fatal cases) has been reported with other agents in this class. Monitor complete blood count in patients with pre-existing low white blood cell count (WBC)/absolute neutrophil count or history of drug-induced leukopenia/neutropenia. Discontinue REXULTI at the first sign ...
Rexulti will continue to carry a Boxed Warning designation for medications in this class. Elderly patients with dementia-related psychosis who are being treated with antipsychotic drugs are at an increased risk of death. More information: